Post-approval studies (Phase 4)Study completedNCT01794793
What this trial is testing
Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies
Who this might be right for
Cushing's DiseaseAcromegalyNeuroendocrine Tumors+6 more
RECORDATI GROUP 337